WASHINGTON--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative:
“BIO applauds today’s bipartisan votes by the Senate HELP Committee to advance legislation as part of the Senate biomedical innovation initiative. In particular, BIO applauds the Committee’s passage of The Advancing Hope Act of 2015, reauthorizing the Pediatric Rare Disease Priority Review Voucher Program, which provides an important incentive for companies developing treatments for rare pediatric diseases. We were also pleased that the Committee passed legislation to add the Zika virus to the Tropical Disease Priority Review Voucher program.
